Multicenter phase II study of second-line cetuximab plus folinic acid/5-fluorouracil/irinotecan (FOLFIRI) in KRAS wild-type metastatic colorectal cancer: the FLIER study.Shigeyoshi Iwamoto, Hideyuki Mishima, Shoichi Hazama et al.|PubMed|2014Cited by 22
Use of microsatellite analysis in young patients with colorectal cancer to identify those with hereditary nonpolyposis colorectal cancerMasakazu Ikenaga, Morito Monden, Nobuteru Kikkawa et al.|Journal of Surgical Oncology|2002Cited by 21
Capecitabine and oxaliplatin combined with bevacizumab are feasible for treating selected Japanese patients at least 75 years of age with metastatic colorectal cancerYoshinori Munemoto, Hideyuki Mishima, Mitsuro Kanda et al.|BMC Cancer|2015Cited by 18
Efficacy of celecoxib as preemptive analgesia for patients undergoing laparoscopic inguinal hernia repair: a randomized trialTakuya Saito, Tsuyoshi Sano, Shigeyoshi Iwamoto et al.|Surgery Today|2021Cited by 7
[Four cases of bevacizumab-related gastrointestinal perforation].Tairin Uchino, Toshiaki Nonami, Hideyuki Mishima et al.|PubMed|2014Cited by 3